| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/25/2013 | CN103463648A Surface modified ferric oxide nucleus-gadolinium oxide shell composite nano particle, as well as preparation method and application of particle |
| 12/25/2013 | CN103463647A Responsive nuclear magnetic resonance contrast agent based on naphthyridine amide as recognition site and preparation method thereof |
| 12/25/2013 | CN103463629A Preparation method and application of premature ovarian failure non-human mammal model |
| 12/25/2013 | CN103463161A Application of Tibet saussurea laniceps extract to relieving fruit fly intestinal inflammation |
| 12/25/2013 | CN102397563B Preparation method for nanometer graphene carrier used for magnetic resonance imaging (MRI) contrast agent |
| 12/25/2013 | CN102327625B Preparation method of water-soluble nano composite material |
| 12/25/2013 | CN102265806B Anti-Alzheimer transgenic Dosophila melanogaster model and application thereof in drug screening |
| 12/24/2013 | US8613920 Treatment of amyloidogenic diseases |
| 12/24/2013 | US8613907 Compositions that inhibit proliferation of cancer cells |
| 12/24/2013 | US8613906 Treatment of ischemia using stem cells |
| 12/24/2013 | CA2666910C Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use |
| 12/24/2013 | CA2395945C Novel chimeric proteins and methods for using the same |
| 12/19/2013 | WO2013188693A1 Antigen binding constructs to cd3 |
| 12/19/2013 | WO2013188470A1 Method and system for in vivo hydrogen peroxide detection with ultrasound |
| 12/19/2013 | WO2013187954A1 Magnetic labeling of bacteria |
| 12/19/2013 | WO2013187283A1 Material for testing eating and deglutition function |
| 12/19/2013 | WO2013186690A2 Radiolabeled analog(s) of compound 0118 and use thereof in connection with pet and/or spect imaging to determine whether a pharmaceutical containing compound 0118 is a candidate cancer treatment for a patient |
| 12/19/2013 | WO2013185487A1 Tumor-targeting multi-mode imaging method for living body based on gold nanoclusters |
| 12/19/2013 | WO2013185204A1 Aggregation and control of magneto-responsive entities |
| 12/19/2013 | US20130336898 Process for preparing a pharmaceutical formulation of contrast agents |
| 12/19/2013 | US20130336897 Theranosis of macrophage-associated diseases with ultrasmall superparamagnetic iron oxide nanoparticles (uspio) |
| 12/19/2013 | US20130336896 Switching-type fluorescent nanoparticle probe, and fluorescent molecular imaging method using same |
| 12/19/2013 | US20130336895 Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
| 12/19/2013 | US20130336894 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications |
| 12/19/2013 | US20130336891 Formulation of acoustically activatable particles having low vaporization energy and methods for using same |
| 12/19/2013 | US20130336889 Nanoparticle and method for detecting or treating a tumor using the same |
| 12/19/2013 | US20130336880 Methods for in vivo identification of cancer initiating cells by multimodality reporter gene imaging |
| 12/19/2013 | CA2875711A1 Aggregation and control of magneto-responsive entities |
| 12/18/2013 | EP2673079A2 Layered bodies, compositions containing them and processes for producing them |
| 12/18/2013 | EP2673006A2 Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same |
| 12/18/2013 | EP2673005A1 Materials and methods relating to cardiovascular imaging |
| 12/18/2013 | EP2673004A1 Hydrophobic modified peptides and their use for liver specific targeting |
| 12/18/2013 | EP2673003A1 Hydrophobic modified peptides for liver specific diagnosis |
| 12/18/2013 | CN103458932A Mri contrast agent for lymphography based on iron oxide nanoparticles and method for imaging lymph node using the same |
| 12/18/2013 | CN103451218A Preparation method of novel cytokine fusion protein IP10 single-chain antibody |
| 12/18/2013 | CN103449530A Preparation method of high-performance magnetic manganese zinc ferrite nanostars and nanoclusters |
| 12/18/2013 | CN103449477A Novel nanometer material contrast agent and application thereof |
| 12/18/2013 | CN103446597A Preparation method of MRI/PET bimodal molecular imaging probe for atherosclerotic vulnerable plaque |
| 12/18/2013 | CN103446596A Gadolinium-series contrast agent with carboxylated short single-walled carbon nanotube modified by hyaluronic acid as carrier as well as preparation method and application of gadolinium-series contrast agent |
| 12/18/2013 | CN103446595A Multifunctional probe for CT (Computed Tomography) and dual-mode fluorescent imaging based on nanometer bismuth sulfide |
| 12/18/2013 | CN103446594A Method for preparing medical defoaming agent from simethicone and differential silicone |
| 12/18/2013 | CN103446588A Targeted diagnosis and treatment combined medicine and preparation method and applications thereof |
| 12/18/2013 | CN103446061A Developing nano-silver sodium alginate microsphere vascular embolizing agent and preparation method thereof |
| 12/18/2013 | CN102350277B Composite microballoon with functions of dual mode imaging and photodynamic activity and preparation method thereof |
| 12/18/2013 | CN101084018B GPR41 and modulators thereof for treatment of insulin-related disorders |
| 12/17/2013 | US8609617 KLF family members regulate intrinsic axon regeneration ability |
| 12/17/2013 | US8609104 Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates |
| 12/17/2013 | US8609067 Method of measuring propulsion in lymphatic structures |
| 12/17/2013 | US8609066 Use of UTP for the diagnosis of stenoses and other conditions of restricted blood flow |
| 12/17/2013 | CA2707233C Organic-inorganic hybrid particles containing contrast agent |
| 12/17/2013 | CA2675342C A method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging |
| 12/17/2013 | CA2556213C Contrast agents for myocardial perfusion imaging |
| 12/17/2013 | CA2547024C Gas-filled microvesicle assembly for contrast imaging |
| 12/17/2013 | CA2498378C Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
| 12/12/2013 | WO2013184786A2 Contrast agents, methods for preparing contrast agents, and methods of imaging |
| 12/12/2013 | WO2013184678A1 Molecular probes for multimodality imaging of anionic membrane surfaces |
| 12/12/2013 | WO2013184193A2 Cancer stem cells and methods of using the same |
| 12/12/2013 | WO2013184061A1 Medical use of particles of titanium and/or titanium oxide |
| 12/12/2013 | WO2013182707A1 Enhanced affinity ligands |
| 12/12/2013 | WO2013181697A1 Bicyclo[6.1.0]non-4-yne compounds suitable for use as linkers in biological applications |
| 12/12/2013 | US20130333058 Pluripotent Cells From Rat and Other Species |
| 12/12/2013 | US20130331690 Vascular imaging agents |
| 12/12/2013 | US20130330280 Aqueous Method of Making Magnetic Iron Oxide Nanoparticles |
| 12/12/2013 | US20130330279 Nanoparticle mediated gene therapy, diagnostic products and therapeutic products for breast cancer |
| 12/12/2013 | US20130330278 MULTICOLORED pH-ACTIVATABLE FLUORESCENCE NANOPLATFORM |
| 12/12/2013 | DE112012001046T5 Stabile kolloidale Goldnanopartikel mit kontrollierbarer Oberflächenmodifizierung und Funktionalisierung Stable colloidal gold nanoparticles with controllable surface modification and functionalization |
| 12/11/2013 | EP2672269A1 Enhanced affinity ligands |
| 12/11/2013 | EP2671570A2 Magnetic nanoparticle, having a curie temperature which is within biocompatible temperature range, and method for preparing same |
| 12/11/2013 | EP2670394A2 Nanoparticles delivery systems, preparation and uses thereof |
| 12/11/2013 | EP2670393A2 Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles. |
| 12/11/2013 | CN103442737A MRI markers, delivery and extraction systems, and methods of manufacture and use thereof |
| 12/11/2013 | CN103432977A Cascaded container and method for pre-polarizing magnetic resonance contrast agent |
| 12/11/2013 | CN103432624A Injectable liquid metal bone cement, preparation method of injectable liquid metal bone cement and special injection device for injectable liquid metal bone cement |
| 12/11/2013 | CN103432602A Micro-capsule ultrasonic contrast agent and preparation method thereof |
| 12/11/2013 | CN103432601A Perfluorooctylbromide coated block polymer ultrasound microbubble contrast agent and preparation method thereof |
| 12/11/2013 | CN103432600A Antibacterial medical ultrasonic coupling agent and preparation method thereof |
| 12/11/2013 | CN103432599A Preparation method of nanometer mangano-manganic oxide nuclear magnetic resonance contrast agent |
| 12/11/2013 | CN103432598A Preparation method of nano rear earth doped gadolinium oxide bi-modal contrast medium |
| 12/11/2013 | CN103432597A Novel multifunctional nano diagnosis and treatment agent based on tumor multi-mode co-therapy and preparation method thereof |
| 12/11/2013 | CN103432596A Method for researching abirritation mechanism of Chinese herbal medicinal ingredients of Xinhuang tablets |
| 12/11/2013 | CN103432585A Targeted marking system for efficiently mediating folate receptor-alpha subtype |
| 12/11/2013 | CN103432572A Rhesus monkey diabetic nephropathy model preparation method |
| 12/11/2013 | CN103432166A Preparation method of stasis-phlegm type ovarian cyst animal model |
| 12/11/2013 | CN103432080A Displayable drug-loaded nano silver sodium alginate microsphere blood vessel embolic agent and preparation method thereof |
| 12/11/2013 | CN103430903A Method for preparing non-human animal model with opportunistic infections and chronic wasting diseases and medicament screened by using same |
| 12/11/2013 | CN103430890A Method for building zebra fish reactive oxygen species (ROS) detection model and application of method |
| 12/11/2013 | CN102796525B Water-phase preparation method of acidity-sensitive CdTe quantum dot modified by double stabilizers |
| 12/11/2013 | CN102470183B Pharmaceutical composition containing dimethicone/ simethicone |
| 12/11/2013 | CN102399822B Construction and application of transgenic mouse model for expressing farnesyl pyrophosphate synthetase |
| 12/11/2013 | CN101869716B System for monitoring bacterial tumor treatment |
| 12/10/2013 | US8604178 Compositions and methods of enhancing immune responses |
| 12/10/2013 | US8603977 Conformationally constrained parathyroid hormone (PTH) analogs |
| 12/10/2013 | US8603976 Methods of enhancing functioning of the large intestine |
| 12/10/2013 | CA2495442C Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 12/05/2013 | WO2013181557A1 Targeting cancer cells and tissue using filamentous plant virus particles |
| 12/05/2013 | WO2013181119A1 Molecular probes for multimodality imaging and tracking of stem cells |
| 12/05/2013 | WO2013181076A1 Coated up-conversion nanoparticles |
| 12/05/2013 | WO2013179014A1 Nanoparticles with attached dna repair inhibitors and nuclear localisation signal elements |
| 12/05/2013 | US20130323316 Injectable microspheres for dermal augmentation and tissue bulking |
| 12/05/2013 | US20130323182 Method of preparing iron oxide nanoparticles coated with hydrophilic material, and magnetic resonance imaging contrast agent using the same |